From the Jan 2019 news about the GNBT purchase of

New Post Public Reply Private Reply Replies (0) Message Board
docj docj #8158
277
From the Jan 2019 news about the GNBT purchase of Olaregen(Excellagen)

"Excellagen has a reimbursement code by the Healthcare Common Procedure Coding System that has a unique Q Code designation 4149 referred to as a skin substitute."

I looked up the code in the Medicare fee schedule and there is no value assigned. Not surprising as "skin substitute" is very generic. Just curious if Olaregen has begun the process of seeing if Medicare is going to cover the product and if so, how much will they reimburse. Are they going to be assigned a more specific HCPCS code for the product?

This code was assigned back 2014.

2019 HCPCS Code Q4149
Excellagen, 0.1 cc

Report Advertisement
Short Description
Excellagen, 0.1 cc
HCPCS Coverage Code
C = Carrier judgment
HCPCS Action Code
N = No maintenance for this code
HCPCS Action Effective Date
January 01, 2014
HCPCS Code Added Date
January 01, 2014
HCPCS Pricing Indicator Code
51 = Drugs
HCPCS Multiple Pricing Indicator Code
A = Not applicable as HCPCS priced under one methodology
HCPCS Type Of Service Code
1 = Medical care
HCPCS Anesthesia Base Unit Quantity
0

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Hassle-Free Cloud Mining with BCC Mining's App

Updated Category News Views 248

Revolutionizing Cloud Mining with BCC Mining Cloud mining has witnessed significant advancements, particularly with the recent introduction of BCC Mining's mobile app. This development marks a new era for cryptocurrency enthusiasts, making it easier than ever to participate in mining activities. Users now have the flexibility to manage their mining operations from...

Continue Reading
CEFALY Launches Research Registry for Pregnant Women’s Migraine Relief

Updated Category News Views 197

CEFALY Introduces the Pregnancy Registry for Migraine Treatment Medical device company CEFALY Technology has recently announced the introduction of the CEFALY Pregnancy Registry, a research initiative aimed at assessing the safety of external trigeminal nerve stimulation (eTNS) for migraine treatment during pregnancy. The Challenge of Managing Migraines During Pregnancy...

Continue Reading
Velocity MSC Expands Offerings with Innovative 5G Communication Solution

Updated Category News Views 234

Velocity MSC Expands Offerings with Innovative 5G Communication Solution Velocity MSC, a trusted name in technological solutions, has announced an exciting addition to its service lineup. The company has incorporated DataRemote's advanced 90X1 5G Plain Old Telephone Service (POTS) replacement solution into its existing offerings. This innovative solution aligns with...

Continue Reading
Exploring the Growth of Interleukin-23 Inhibitors Market Ahead

Updated Category News Views 148

Interleukin-23 Inhibitors Market Overview The interleukin-23 inhibitors market is currently experiencing significant growth, fueled by the escalating prevalence of autoimmune diseases such as psoriasis and inflammatory bowel disease. With innovations in biologics and increasing acceptance of targeted therapies, the demand for these treatments continues to surge....

Continue Reading
Hexagon AB to Spin Off Asset Lifecycle Intelligence Division

Updated Category News Views 671

Hexagon Plans Spin-Off for Enhanced Focus and Growth Hexagon AB is embarking on an exciting journey towards the spin-off of its Asset Lifecycle Intelligence (ALI) division and associated businesses. This significant decision, made by the Board of Directors, aims to separate ALI into a new entity that will allow both Hexagon and the new organization, referred to as NewCo,...

Continue Reading